Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2013 Jul;208(1):40-9.
doi: 10.1093/infdis/jis731. Epub 2012 Nov 29.

Factors associated with adherence amongst 5295 people receiving antiretroviral therapy as part of an international trial

Jemma L O'Connor  1 , Edward M Gardner, Sharon B Mannheimer, Alan R Lifson, Stefan Esser, Edward E Telzak, Andrew N Phillips; INSIGHT SMART Study Group
Affiliations
Randomized Controlled Trial

Factors associated with adherence amongst 5295 people receiving antiretroviral therapy as part of an international trial

Jemma L O'Connor et al. J Infect Dis. 2013 Jul.

Abstract

Background: We assessed factors associated with antiretroviral therapy (ART) adherence, including specific ART medications.

Methods: The Strategies for Management of Antiretroviral Therapy study was an international antiretroviral therapy (ART) strategy trial that compared intermittent ART, using CD4(+) T-cell count as a guide, to continuous ART. Adherence during the 7 days before each visit was measured using self-report. We defined high adherence as self-report of taking "all" pills for each prescribed ART medication; all other reports were defined as suboptimal adherence. Factors associated with adherence were assessed using logistic regression with generalized estimating equations.

Results: Participants reported suboptimal adherence at 6016 of 35 695 study visits (17%). Factors independently associated with suboptimal adherence were black race, protease inhibitor-containing regimens, greater pill burden, higher maximum number of doses per day, and smoking. Factors independently associated with higher adherence were older age, higher education, region of residence, episodic treatment, higher latest (at the time of adherence) CD4(+) T-cell count, and being prescribed concomitant drugs (ie, medications for comorbidities). Of specific drugs investigated, atazanavir, atazanavir/ritonavir, fosamprenavir, indinavir, indinavir/ritonavir, and lopinavir/ritonavir were associated with suboptimal adherence, and tenofovir disoproxil fumarate/emtricitabine was associated with higher adherence.

Conclusions: In this, the largest analysis of ART adherence to date, some protease inhibitor-containing regimens and regimens with >1 dose per day were associated with suboptimal adherence.

Keywords: HIV infection; adherence; antiretroviral drugs; self-report.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Consistency of adherence over blocks of 5 consecutive visits (12 856 blocks contributed; participants can contribute >1 block).
See this image and copyright information in PMC

References

    1. Cambiano V, Lampe FC, Rodger AJ, et al. Long-term trends in adherence to antiretroviral therapy from start of HAART. AIDS. 2010;24:1153–62. - PubMed
    1. El-Sadr WM, Lundgren JD, Neaton JD, et al. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med. 2006;355:2283–96. - PubMed
    1. Lima VD, Harrigan R, Bangsberg DR, et al. The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time. J Acquir Immune Defic Syndr. 2009;50:529–36. - PMC - PubMed
    1. Martin M, Del Cacho E, Codina C, et al. Relationship between adherence level, type of the antiretroviral regimen, and plasma HIV type 1 RNA viral load: a prospective cohort study. AIDS Res Hum Retroviruses. 2008;24:1263–8. - PubMed
    1. Mocroft A, Vella S, Benfield TL, et al. Changing patterns of mortality across Europe in patients infected with HIV-1. Lancet. 1998;352:1725–30. - PubMed

Publication types

Substances